Managing CLL as a chronic disease in the long term to improve overall outcome

Arnon Kater, MD, PhD, University of Amsterdam, Amsterdam, Netherlands, shares some insights into the long-term management of chronic lymphocytic leukemia (CLL) to improve overall outcome. Dr Kater first highlights the long treatment horizon associated with CLL, and the opportunity for time-limited therapy to be used in the future. Dr Kater then emphasizes the importance of considering the psychological well-being and quality of life of patients during treatment. To conclude, Dr Kater explains how clinicians can take a more holistic approach when treating CLL, and should pay special attention to other underlying immune disorders, as well as increased risk for infection and other malignancies. This interview took place during the 2nd ESH Translational Research Conference on Chronic Lymphocytic Leukemia (ESH CLL), 2022.